Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengqi Qiu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|May 21, 2024
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cellsFengqi Qiu, Peishan Jiang, Guiheng Zhang, et al.
Sensors (Basel, Switzerland)|January 23, 2024
Overview of Health-Monitoring Technology for Long-Distance Transportation Pipeline and Progress in DAS Technology ApplicationYuyi Wu, Lei Gao, Jing Chai, et al.
NPJ Precision Oncology|January 31, 2024
CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancerWenjia Sun, Fengqi Qiu, Jing Zheng, et al.
Molecular Cell|November 28, 2023
CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunityGuiheng Zhang, Peishan Jiang, Wen Tang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|May 21, 2024
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cellsFengqi Qiu, Peishan Jiang, Guiheng Zhang, et al.
Sensors (Basel, Switzerland)|January 23, 2024
Overview of Health-Monitoring Technology for Long-Distance Transportation Pipeline and Progress in DAS Technology ApplicationYuyi Wu, Lei Gao, Jing Chai, et al.
NPJ Precision Oncology|January 31, 2024
CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancerWenjia Sun, Fengqi Qiu, Jing Zheng, et al.
Molecular Cell|November 28, 2023
CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunityGuiheng Zhang, Peishan Jiang, Wen Tang, et al.
Pageof 2